HomeInsightsStock Comparison

Dr Agarwals Eye Hospital Ltd vs Jupiter Life Line Hospitals Ltd Stock Comparison

Dr Agarwals Eye Hospital Ltd vs Jupiter Life Line Hospitals Ltd Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

  • The Latest Trading Price of Dr Agarwals Eye Hospital Ltd is ₹ 5280 as of 30 Oct 15:30 . The P/E Ratio of Dr Agarwals Eye Hospital Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Jupiter Life Line Hospitals Ltd changed from 44.5 on March 2024 to 43 on March 2026 . This represents a CAGR of -1.14% over 3 years The Market Cap of Dr Agarwals Eye Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Jupiter Life Line Hospitals Ltd changed from ₹ 7853 crore on March 2024 to ₹ 8344 crore on March 2026 . This represents a CAGR of 2.04% over 3 years The revenue of Dr Agarwals Eye Hospital Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 467.04 crore as compare to the Jun '26 revenue of ₹ 421.57 crore. This represent the growth of 10.79% The ebitda of Dr Agarwals Eye Hospital Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 117.39 crore as compare to the Jun '26 ebitda of ₹ 89.86 crore. This represent the growth of 30.64% The net profit of Dr Agarwals Eye Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Jupiter Life Line Hospitals Ltd changed from ₹ 44.61 crore to ₹ 56.36 crore over 10 quarters. This represents a CAGR of 9.80% The Dividend Payout of Dr Agarwals Eye Hospital Ltd changed from 5.85 % on March 2022 to 4.82 % on March 2026 . This represents a CAGR of -3.80% over 5 yearsThe Dividend Payout of Jupiter Life Line Hospitals Ltd changed from 4.32 % on March 2024 to 3.43 % on March 2026 . This represents a CAGR of -7.40% over 3 years .

About Dr Agarwals Eye Hospital Ltd

  • Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994.
  • The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu.
  • Company has been a pioneer and leader into the Indian Ophthalmology market in the eye care division.
  • It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others.
  • It has presence in Tamil Nadu, Kerala and Rajasthan states. The Company is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.

About Jupiter Life Line Hospitals Ltd

  • Jupiter Life Line Hospitals Limited was incorporated in Mumbai, Maharashtra through a Certificate of Incorporation dated November 18, 2002, issued by the RoC, which subsequently, commenced its business operations in December, 2002.
  • Led by founding Promoter, Dr. Ajay Thakker, the Company is a prominent multi-speciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and Western India with total operational bed capacity of 1,194 across three hospitals located in Thane, Pune and Indore under the 'Jupiter' brand.
  • The Company is constructing a new multi-speciality hospital in Dombivali, Maharashtra with potential capacity of 500 beds.
  • The Company is also running Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company follow a patient first' ideology by creating the best infrastructure, technology and support to put the patient first and foremost and be futuristic and innovative in delivery of healthcare.

FAQs for the comparison of Dr Agarwals Eye Hospital Ltd and Jupiter Life Line Hospitals Ltd

Which company has a larger market capitalization, Dr Agarwals Eye Hospital Ltd or Jupiter Life Line Hospitals Ltd?

Market cap of Dr Agarwals Eye Hospital Ltd is 2,551 Cr while Market cap of Jupiter Life Line Hospitals Ltd is 8,402 Cr

What are the key factors driving the stock performance of Dr Agarwals Eye Hospital Ltd and Jupiter Life Line Hospitals Ltd?

The stock performance of Dr Agarwals Eye Hospital Ltd and Jupiter Life Line Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Agarwals Eye Hospital Ltd and Jupiter Life Line Hospitals Ltd?

As of October 31, 2026, the Dr Agarwals Eye Hospital Ltd stock price is INR ₹5280.15. On the other hand, Jupiter Life Line Hospitals Ltd stock price is INR ₹256.3.

How do dividend payouts of Dr Agarwals Eye Hospital Ltd and Jupiter Life Line Hospitals Ltd compare?

To compare the dividend payouts of Dr Agarwals Eye Hospital Ltd and Jupiter Life Line Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions